AptarGroup reports Q2 EPS $1.67, consensus $1.59

Reports Q2 revenue $966.0M, consensus $956.9M. “Each of our segments contributed positively to our second quarter results and each expanded their adjusted EBITDA margins. Our Pharma and Closures segments drove the growth through increased volumes and sales of higher value products. We also returned $100 million to shareholders through dividends and share repurchases in the quarter, bringing the total to $210 million in the first half of the year,” said Stephan B. Tanda, Aptar President and CEO.